|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 16/40 | (2006.01) |
| (11) | Number of the document | 3280440 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16777134.4 |
| Date of filing the European patent application | 2016-04-05 | |
| (97) | Date of publication of the European application | 2018-02-14 |
| (45) | Date of publication and mention of the grant of the patent | 2022-11-16 |
| (46) | Date of publication of the claims translation | 2023-02-27 |
| (86) | Number | PCT/US2016/026038 |
| Date | 2016-04-05 |
| (87) | Number | WO 2016/164358 |
| Date | 2016-10-13 |
| (30) | Number | Date | Country code |
| 201562143636 P | 2015-04-06 | US | |
| 201562200997 P | 2015-08-04 | US |
| (72) |
PANICKER, Sandip , US
PARRY, Graham , US
|
| (73) |
Bioverativ USA Inc. ,
951 Gateway Boulevard, South San Francisco, California 94080,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Humanizuoti antikūnai prieš C1s ir jų panaudojimo būdai |
| HUMANIZED ANTI-C1S ANTIBODIES AND METHODS OF USE THEREOF |
| Payment date | Validity (years) | Amount | |
| 2026-03-03 | 11 | 289.00 EUR |
| 2027-04-05 |